In contrast, CDKN1A upregulation reinforced the cell cycle arrest observed in tumor cells, while FABP1 and BCL2A1 suggest metabolic and apoptotic adjustments in the post-knockdown state. This evidence concerns the gene BCL2A1 and neoplasm.